logo

Zentalis Pharmaceuticals Inc (ZNTL) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Zentalis Pharmaceuticals Inc’s current trading price is -83.55% away from its 52-week high, while its distance from the 52-week low is 11.78%. The stock’s price range during this period has varied between $2.66 and $18.07. The company, active in the Healthcare sector, saw a trading volume of around 1.42 million for the day, considerably higher average daily volume of 1.28 million observed over the last three months.

Zentalis Pharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $18.07 on 02/28/24, and the lowest price during the same period was recorded at $2.66 on 10/31/24.

How Financial Performance Impacts Market Capitalization

Zentalis Pharmaceuticals Inc (ZNTL) has experienced a quarterly decline of -1.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 211.90M and boasts a workforce of 168 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.32, with a change in price of -0.20. Similarly, Zentalis Pharmaceuticals Inc recorded 1,716,955 in trading volume during the last 100 days, posting a change of -6.23%.

How ZNTL’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ZNTL stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.

ZNTL Stock Stochastic Average

As of today, the raw stochastic average of Zentalis Pharmaceuticals Inc over the past 50 days is 15.45%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 19.07%. Additionally, the Stochastic %K and %D values for the company were 8.03% and 10.20%, respectively, over the past 20 days.

ZNTL Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -1.87%.However, over the last six months, we can see a stronger performance of -25.29%. Over the last 30 days, the price of ZNTL has leaped by -23.57%. And in the last five days, it has fallen by -0.89%.

Most Popular